News Flash Home
The original item was published from 8/6/2020 4:32:36 PM to 8/7/2021 12:00:07 AM.

News Flash

Home

Posted on: August 6, 2020

[ARCHIVED] COVID-19 Research Volunteers Needed

Please let your citizens know about these heroic service opportunities.

First, anyone who has recovered from the virus, who has been symptom-free for at least 14 days, and who is otherwise able to donate blood, could be eligible to save lives by donating their convalescent plasma.

Convalescent plasma is the liquid part of blood that is collected from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. COVID-19 patients develop antibodies in the blood against the virus. Antibodies are proteins that might help fight the infection. Convalescent plasma is being investigated for the treatment of COVID-19. There is no approved treatment for this disease, but there are promising indications that COVID-19 convalescent plasma might help some patients recover.

Demand continues to exceed supply. To learn more about the process or find the nearest site, interested parties can visit:

AABB

America’s Blood Centers

American Red Cross

Blood Centers of America

CoVIg-19 Plasma Alliance

National COVID-19 Convalescent Plasma Project

Plasma Protein Therapeutics Association

The Fight Is In Us

Second, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

Anyone interested can learn more, and, should they decide to go forward, see if they qualify to volunteer.

The COVID-19 Prevention Trials Network (COVPN) was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network (HVTN), based in Seattle; the HIV Prevention Trials Network (HPTN), based in Durham, N.C.; the Infectious Diseases Clinical Research Consortium (IDCRC), based in Atlanta; and the AIDS Clinical Trials Group, based in Los Angeles. Those individual networks will continue to perform clinical trials for HIV vaccine and prevention and other infectious diseases in addition to their new COVID roles.

Facebook Twitter Email

Other News in Home

CY 2022 Audit Deadline Extended

Posted on: May 12, 2023

House Passes Debt Limit Bill

Posted on: April 28, 2023

President Biden Proposes FY24 Budget

Posted on: March 10, 2023

SHBC Plan Design Committee Meeting Summary

Posted on: February 24, 2023

FY2023 Federal Omnibus Budget Passed

Posted on: January 9, 2023

SHBP Update: No Relief In New Year

Posted on: December 30, 2022

Federal Budget Update

Posted on: December 23, 2022

LEAP Grants Now Available

Posted on: December 23, 2022

Federal Budget Update

Posted on: December 19, 2022

State Health Benefits Update

Posted on: December 5, 2022

Revised Model Procurement Forms

Posted on: December 5, 2022

SHBP Rate Increase Adopted

Posted on: September 27, 2022

Blog Post: Available Federal Grants

Posted on: September 27, 2022

President Signs CHIPS and Science Act

Posted on: August 12, 2022

Ground Broken on Portal North Bridge

Posted on: August 8, 2022

Energy Tax Receipt Funding Update

Posted on: June 29, 2022

FY2023 Budget Update

Posted on: June 29, 2022